Melissa Greenleaf, Clinical trials manager at the Walter Reed Army institute of Research's Clinical Trials Center, injects participant Melanie Limerick with the FMP013 Malaria vaccine during a clinical trial, April 27, 2021. The trial involves a series of three injections of the vaccine followed by direct exposure to Malaria, Ultimately aiming to find a safe and effective vaccine against Malaria. (U.S. Army photo by Mike Walters/Released)
| Date Taken: | 04.27.2021 |
| Date Posted: | 04.27.2021 13:47 |
| Photo ID: | 6618151 |
| VIRIN: | 210427-A-PR201-042 |
| Resolution: | 3337x2225 |
| Size: | 5.02 MB |
| Location: | SILVER SPRING, MARYLAND, US |
| Web Views: | 61 |
| Downloads: | 10 |
This work, WRAIR CTC FMP013 Malaria Vaccine Trial [Image 6 of 6], by Mike Walters, identified by DVIDS, must comply with the restrictions shown on https://www.dvidshub.net/about/copyright.
Malaria vaccine candidate safe and immunogenic following first-in-human trials
No keywords found.
